Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-1110 in Patients With Postherpetic Neuralgia
NCT06708416Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Feb 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ONO-1110 in postherpetic neuralgia (PHN), sponsored by Ono Pharmaceutical. Started Feb 2025; status: completed.
02
Drugs
ONO-1110
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT06708416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06708416.